Congratulations to Dr. Peter Dosa of the ITDD, who received an Investigator-Initiated Research Award of $2,278,764. The project will be funded by the Department of Defense's Congressionally Directed Medical Research Programs.
The grant was awarded for Dr. Dosa's project "Development of Gut-Restricted Bile Acid Analogs Inhibitory to C. difficile Infection," which seeks to develop a treatment to C. difficile infections that often develops as a result of antibiotic overuse. By researching and utilizing bile acids that occur naturally in the body, Dosa's team hopes to derive therapeutic compounds that can be used to inhibit the C. difficile infection, as an alternative to current fecal microbiota transplant treatments.
You can read more about Dr. Dosa's project here.
